Navigation Links
Amorcyte Stem Cell Therapy Demonstrates Clinically Significant Reperfusion in Severe Heart Attack Patients
Date:12/21/2010

re heart attack.  We look forward to further evaluating AMR-001 in a larger Phase II trial where we look toward duplicating the neoangiogenisis achieved in the Phase I trial and also to achieve a significant reduction in downstream adverse events typically resulting from AMI."

About Cardiovascular Disease

It is estimated that each year there are approximately 1.1 million instances of acute myocardial infarction (AMI).  160,000 AMIs are severe enough to cause ventricular remodeling leading to further tissue damage over time and downstream adverse events including premature death, recurrent myocardial infarction, congestive heart failure, significant arrhythmias and acute coronary syndrome.  Amorcyte's therapy aims to limit ventricular remodeling.

About Amorcyte, Inc.

Amorcyte is a privately held biotechnology company developing cell therapy products to treat cardiovascular disease.  Its lead product AMR-001, for the prevention of major adverse cardiac events following acute myocardial infarction (AMI), has completed Phase I clinical trials demonstrating feasibility, safety and biologic activity at a threshold dose.  This is the first stem cell trial in AMI ever conducted that has prospectively established a significant relationship between dose and effect.  Amorcyte has partnered with Progenitor Cell Therapy, a leading provider of clinical, manufacturing and other services for the cell therapy industry, to provide Amorcyte with a pharmaceutical grade cGMP manufactured product that can be distributed commercially.  Amorcyte was founded by Andrew Pecora, M.D., Chairman of The John Theurer Cancer Center at Hackensack University Cancer Center, with initial investment by Novitas Capital and Colt Ventures.  Additional information about Amorcyte can be found at: www.amorcyte.com


'/>"/>
SOURCE Amorcyte, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Advanced Laser Therapy Solutions for Womens Hair Loss
2. Physiotherapy Associates Announces New Multiple Sclerosis Specialty Treatment Program
3. Study Shows Novartis Drug Afinitor® Plus Hormonal Therapy Delays Disease Progression in Advanced Metastatic Breast Cancer Patients
4. New York Robotic Surgery Expert Dr. David Samadi, MD Discusses New Findings that Hormone Therapy May Increase Risk of Developing Colorectal Cancer
5. Passages Malibu Drug and Alcohol Treatment Center Announces Launch of Cutting-Edge Brain Paint Neurofeedback Therapy Scientifically Proven to Reduce Addiction Relapse Rate Into Pioneering Holistic Treatment Program
6. Elekta Receives FDA 510(k) Clearance for XiO Software to Plan Spot Scanning for Proton Therapy
7. Neuraltus Pharmaceuticals Reports Clinical Results from Phase 1/2 NP002 Study in the Treatment of Dyskinesias Resulting from Levodopa Therapy for Parkinsons Disease
8. VeriStrat® Test Identifies Lung Cancer Patients Benefiting from Combination Therapy
9. Marshall Edwards Announces Presentation of New Data Showing Activity in Chemotherapy-Resistant Ovarian Cancer Cells
10. Exempla Saint Joseph Hospital Commences Treating Cancer Patients Using New TrueBeam™ System for High-Precision Image-Guided Radiotherapy and Radiosurgery
11. NT-proBNP Guided Therapy Keeps Heart Failure Patients out of the Hospital Through a Reduction in Cardiovascular Events
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... 19, 2014  Boehringer Ingelheim today announced that ... for review the New Drug Application (NDA) for ... delivered via the Respimat ® inhaler for ... of airflow obstruction in patients with chronic obstructive ... Tiotropium + olodaterol FDC will not be indicated ...
(Date:8/19/2014)... -- Cardiva Medical, Inc. announced today that it has closed ... 3 private equity financing and a $12.5 million senior ... the proceeds of the Series 3 private equity financing ... VASCADE® Vascular Closure System in the United ... 3 private equity financing was a new investor, Canepa ...
(Date:8/19/2014)... Aug. 19, 2014  Sequence, Inc., an industry leader in ... and medical device manufacturers is opening a third office location ... , as a result of demand by clients to ... opened this month, allows Sequence to better serve new and ... St. Louis office provides Sequence a hub ...
Breaking Medicine Technology:Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 2Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 3Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 4Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 5Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 6Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 7Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 8Cardiva Medical, Inc. Announces Completion of the first two tranches of Series 3 Private Equity Financing and the Closing of a Senior Secured Debt Facility with GE Capital 2Quality and Compliance Solutions Provider Announces Opening of St. Louis, Missouri Office 2
... FRANCISCO, Calif., June 01, 2007,/PRNewswire-FirstCall/ -- Sunesis Pharmaceuticals, ... from ongoing clinical,studies of SNS-595 and SNS-032 at ... being held June 7-10, 2007 in Vienna,Austria. , ... Phase 1 clinical trial of SNS-595 in acute ...
... Zurich, June 1, 2007-Cytos Biotechnology AG is ... presentations of its novel,immunotherapeutic CYT003-QbG10 to treat ... were obtained,and will be presented in different ... Academy of Allergology and Clinical Immunology,(EAACI), taking ...
Cached Medicine Technology:Sunesis Pharmaceuticals to Present Data at the 12th Congress of the,European Hematology Association 2Sunesis Pharmaceuticals to Present Data at the 12th Congress of the,European Hematology Association 3CYT003-QbG10 to treat allergy to be presented at the Congress of,the European Academy of Allergology and Clinical Immunology,(EAACI), June 9-13, 2007 2
(Date:8/19/2014)... (PRWEB) August 20, 2014 Midtown Dentistry in ... amalgam-free dental office. All patients with cavities, or with ... latest white fillings that can safely repair and restore teeth. ... the very latest materials, all of which are completely amalgam ... safe for use by the FDA for adults and children ...
(Date:8/19/2014)... What gives skin an edge and is that "something ... nourish it while lightly exfoliating? The Collagen Antioxidant ... about how their skin feels and looks after using the ... "The ingredients are very rich and spa-quality." , The special ... cleansed skin of the face and neck, and let it ...
(Date:8/19/2014)... editorial published in this week,s JAMA highlights ... tools when considering how to treat patients. Written by ... Center and chair of pediatrics at Boston University School ... JAMA , the editorial examines results of a study ... an example of how doctors can often over-emphasize certain ...
(Date:8/19/2014)... (PRWEB) August 20, 2014 LunaDress, a ... and cocktail dresses for ladies, is now providing a ... prom dresses . The company’s cheap white prom outfits ... V-neck, backless, and A-line outfits. , There are ... company’s product category, and the special offer is valid ...
(Date:8/19/2014)... 2014 Top10BestSEOHosting.com has recently announced ... the recommended suppliers for the webmasters who want ... , According to the senior spokesman for Top10BestSEOHosting.com, ... affordable hosting products on the market and specializes ... variety of online deals when service plans are ...
Breaking Medicine News(10 mins):Health News:Midtown Dentistry Announces It Is Now an Amalgam-Free Office 2Health News:That "Something Special" to Improve Skin Takes Only 10 Minutes Per Week; on Sale at Sublime Beauty® 2Health News:Review of clinical treatment of bronchiolitis in infants reveals over-reliance on one test 2Health News:Popular Supplier LunaDress Providing an Exclusive Assortment of White Prom Dresses at a Discount of Up to 67% 2Health News:Fatcow Awarded As One of the Best Web Hosting Suppliers at Top10bestseohosting.com 2
... ... a leading provider of information-based technology services to the health care industry, ... Texas in addition to its services that are provided to physicians throughout ... New Hampshire and is owned by Medical Protective, part of the Berkshire ...
... NJ A recent study published in International ... extract from the bark of the French maritime pine ... associated with various health problems. Dr. Raffaella Canali ... in Rome, Italy, found that Pycnogenol inhibits the generation ...
... , , PORTLAND, Ore., ... reform is the power of simple questions that people can ask each ... , To spark this effort, Regence BlueCross ... to inspire debate, discussion, and ultimately engagement and action by consumers. As ...
... , , CARY, N.C., ... CRTX ), a specialty pharmaceutical company focused on acquiring, ... and related markets, today announced that it has submitted ... Administration (FDA) for an extended-release antitussive product (CRTX 067) ...
... HARRISBURG, Pa., July 15 The Department of Environmental Protection and ... day for June 16 in the Philadelphia region. , ... will be code ORANGE for ozone in the region, which includes ... , The U.S. Environmental Protection Agency,s standardized ...
... , PITTSBURGH, Jul. 15 Leo W. Gerard, President ... to the U.S. House of Representatives, health care reform bill. , ... ) , , ... of efforts by the U.S. House leadership to fix our broken ...
Cached Medicine News:Health News:Garnet Health -- A Leader in the Healthcare Industry Expands its Operations 2Health News:Garnet Health -- A Leader in the Healthcare Industry Expands its Operations 3Health News:Study demonstrates the anti-inflammatory properties of pine bark extract 2Health News:Regence Launches Effort to Further Health Care Debate 2Health News:Regence Launches Effort to Further Health Care Debate 3Health News:Cornerstone Therapeutics Submits Regulatory Filing for Extended-Release Antitussive Product 2Health News:Cornerstone Therapeutics Submits Regulatory Filing for Extended-Release Antitussive Product 3Health News:Cornerstone Therapeutics Submits Regulatory Filing for Extended-Release Antitussive Product 4Health News:Cornerstone Therapeutics Submits Regulatory Filing for Extended-Release Antitussive Product 5Health News:Air Quality Action Day Forecast for July 16 in Philadelphia Region 2Health News:Statement by USW President Leo W. Gerard on U.S. House Health Care Reform Bill 2
... A lower cost alternative to Equalizers, the patented ... between two different vessel configurations. With the push ... be quickly and easily adjusted for test tubes ... Ergonomic Design for Unparalleled Comfort Pick one ...
... 384 Well Plate Capability The Equalizer ... original Equalizerexpandable and equal tip spacing, choice of ... capabilities. In addition, this model allows you to ... loading and accessing many gels and for use ...
... The Equalizer With 384 Well Plate Capability ... revolutionary features of the original Equalizerexpandable and equal ... components, and in-lab calibration capabilities. In addition, this ... down to 4.5mm for loading and accessing many ...
... Equally Spaced, Expandable, Multichannel Pipettor ... pipettors and instantly boosts productivity with an ... the simple adjustment of a slide rod. ... transfer of liquids between vessels with different ...
Medicine Products: